TC
ARRY

TFS Capital’s Array Biopharma Inc ARRY Stock Holding History

TFS Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-120,612
Closed -$550K – 1015
2015
Q3 		$550K Sell
120,612
-671,959
-85% -$3.98M 0.05% 495
2015
Q2 		$5.71M Buy
792,571
+190,120
+32% +$1.4M 0.56% 14
2015
Q1 		$4.44M Buy
+602,451
New +$4.29M 0.43% 35
2014
Q3 		– Sell
-26,591
Closed -$121K – 1315
2014
Q2 		$121K Buy
+26,591
New +$110K 0.01% 1029
2014
Q1 		– Sell
-319,430
Closed -$1.6M – 1696
2013
Q4 		$1.6M Sell
319,430
-393,061
-55% -$2.14M 0.08% 379
2013
Q3 		$4.43M Sell
712,491
-37,869
-5% -$225K 0.2% 117
2013
Q2 		$3.41M Buy
+750,360
New +$4.04M 0.14% 182

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TFS Capital's ARRY Position: Q4 2015 in Review

TFS Capital sold out of Array Biopharma Inc (ARRY) in Q4 2015, closing a stake of 120,612 shares — an estimated $550K sold.

TFS Capital first reported a position in ARRY in Q2 2013 and held it in 7 quarters. The position peaked at $5.71M in Q2 2015. 151 funds tracked by Wall St. Rank hold ARRY as of Q4 2015.

  • TFS Capital reported no remaining Array Biopharma Inc position as of Q4 2015 after selling out during the quarter.
  • TFS Capital sold 120,612 Array Biopharma Inc shares in Q4 2015, an estimated $550K.
  • TFS Capital first reported a position in Array Biopharma Inc in Q2 2013 and held it in 7 quarters.
  • TFS Capital's Array Biopharma Inc position peaked at $5.71M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2015.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.